Task: Answer the multiple-choice question.
Query: Which compound exhibits a 5.285% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] C#CCn1cc[n+](CC(=O)N(C)C)c1.[Br-]
[b] COC(=O)C1=C(c2ccccc2OCc2ccccc2)C[C@@H]2CC[C@H]1N2C(=O)NCc1ccc(OC)cc1
Answer: a. C#CCn1cc[n+](CC(=O)N(C)C)c1.[Br-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCn1cc[n+](CC(=O)N(C)C)c1.[Br-]
C#CCn1cc[n+](CC(=O)N(C)C)c1.[Br-]
N,N-dimethyl-2-(3-prop-2-ynylimidazol-1-ium-1-yl)acetamide;bromide